1. Home
  2. ILMN vs ARE Comparison

ILMN vs ARE Comparison

Compare ILMN & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ILMN
  • ARE
  • Stock Information
  • Founded
  • ILMN 1998
  • ARE 1994
  • Country
  • ILMN United States
  • ARE United States
  • Employees
  • ILMN N/A
  • ARE N/A
  • Industry
  • ILMN Medical Specialities
  • ARE Real Estate Investment Trusts
  • Sector
  • ILMN Health Care
  • ARE Real Estate
  • Exchange
  • ILMN Nasdaq
  • ARE Nasdaq
  • Market Cap
  • ILMN 23.6B
  • ARE 19.3B
  • IPO Year
  • ILMN 2000
  • ARE 1997
  • Fundamental
  • Price
  • ILMN $135.24
  • ARE $99.91
  • Analyst Decision
  • ILMN Buy
  • ARE Buy
  • Analyst Count
  • ILMN 17
  • ARE 11
  • Target Price
  • ILMN $163.12
  • ARE $127.36
  • AVG Volume (30 Days)
  • ILMN 2.3M
  • ARE 1.4M
  • Earning Date
  • ILMN 02-06-2025
  • ARE 01-27-2025
  • Dividend Yield
  • ILMN N/A
  • ARE 5.31%
  • EPS Growth
  • ILMN N/A
  • ARE 18.05
  • EPS
  • ILMN N/A
  • ARE 1.64
  • Revenue
  • ILMN $4,390,000,000.00
  • ARE $3,085,452,000.00
  • Revenue This Year
  • ILMN N/A
  • ARE N/A
  • Revenue Next Year
  • ILMN $4.05
  • ARE $0.13
  • P/E Ratio
  • ILMN N/A
  • ARE $60.46
  • Revenue Growth
  • ILMN N/A
  • ARE 10.21
  • 52 Week Low
  • ILMN $97.36
  • ARE $97.14
  • 52 Week High
  • ILMN $156.66
  • ARE $131.36
  • Technical
  • Relative Strength Index (RSI)
  • ILMN 40.07
  • ARE 36.18
  • Support Level
  • ILMN $130.31
  • ARE $97.14
  • Resistance Level
  • ILMN $137.69
  • ARE $99.48
  • Average True Range (ATR)
  • ILMN 5.08
  • ARE 2.39
  • MACD
  • ILMN -1.03
  • ARE -0.15
  • Stochastic Oscillator
  • ILMN 21.62
  • ARE 23.18

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a significant market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, agtech, and technology campuses that provide tenants with highly dynamic and collaborative environments. Alexandria also provides strategic capital to transformative life science, agtech, and technology companies through venture capital platform.

Share on Social Networks: